SAN FRANCISCO, Nov. 30, 2021 /PRNewswire/ -- Enlitic, in
collaboration with Konica Minolta Inc. and Marubeni Corporation,
today announced that its AI-powered product for analyzing chest
X-rays – CXR-AI – has received approval from Japanese regulators
and will be available commercially across Japan. With this approval, Enlitic became the
first U.S. imaging AI company to receive regulatory approval to
commercialize in Japan.
CXR-AI, which is developed with Enlitic's AI technology, better
detects major abnormal findings such as lung nodule and
consolidation in chest X-ray images. The findings that are detected
by CXR-AI software are shown as a simple mark for each abnormality
allowing radiologists to easily and quickly identify
abnormalities.
"CXR-AI is the culmination of several months of collaboration
between Konica Minolta and Enlitic. It has been validated with
great results at the leading medical institutions in Japan," said Kazuhiko Katsushima, Senior
Manager, Planning Division of Healthcare IT Business Operations,
Konica Minolta. "Significant
expectations have emerged for utilization of AI especially in
health screening and we believe that this product will truly make a
difference for the radiologists and patients in Japan and we look forward to working together
on future projects."
Konica Minolta is the leading medical imaging company in
Japan and Marubeni is a leading
Japanese conglomerate. Enlitic, Konica Minolta and Marubeni have a
long-standing relationship and Marubeni is also a strategic
shareholder in Enlitic.
"Japan is the second largest
radiology market in the world and we are very excited to bring
CXR-AI to the Japanese market. We have great aspirations to develop
and commercialize our differentiated AI products in Japan alongside Konica Minolta and Marubeni,"
said James Conyers, CEO of
Enlitic.
CXR-AI will be deployed with Konica Minolta's PACS and AI
gateway systems to be distributed across hospitals, clinics, and
other medical institutions in Japan. Marubeni Corporation will
also facilitate the commercialization of CXR-AI through other
channels in Japan.
ABOUT ENLITIC
Enlitic is a pioneer in developing the
next generation of intelligent healthcare tools. Founded in 2014,
the company takes a different approach to solving today's
healthcare challenges addressing them throughout the clinical
workflow – not just at one point in the process. Using Enlitic's
AI-powered workflow solutions, healthcare organizations can unlock
the true value of their data in real-time, providing time-saving
solutions that help change patient lives, while giving clinicians
and radiologists more freedom to focus on what's important on the
job and in their everyday lives. For more information, visit
www.enlitic.com.
ABOUT KONICA MINOLTA, INC.
Konica Minolta is a
world-class provider and market leader in medical diagnostic
imaging and healthcare information technology. With over 75 years
of endless innovation, Konica Minolta is globally recognized as a
leader providing cutting-edge technologies and comprehensive
support aimed at providing real solutions to meet customers' needs
and helping make better decisions sooner. Konica Minolta Healthcare
Americas, Inc., headquartered in Wayne,
NJ, is a unit of Konica Minolta, Inc. (TSE:4902). For more
information on Konica Minolta Healthcare Americas, Inc., please
visit https://healthcare.konicaminolta.us
ABOUT MARUBENI CORPORATION
Marubeni Corporation is a
major Japanese integrated trading and investment business
conglomerate that handles products and provides services in a broad
range of sectors. These areas encompass importing and exporting, as
well as transactions in the Japanese market, related to food
materials, food products, textiles, materials, pulp and paper,
chemicals, energy, metals and mineral resources, transportation
machinery, and includes offshore trading. The Company's activities
also extend to power projects and infrastructure, plants and
industrial machinery, finance, logistics and information industry,
and real estate development and construction. Additionally,
Marubeni conducts business investment, development and management
on a global level. For more information visit,
http://www.marubeni.com/en
View original content to download
multimedia:https://www.prnewswire.com/news-releases/enlitic-becomes-first-us-imaging-ai-company-to-receive-regulatory-approval-to-commercialize-in-japan-301433492.html
SOURCE Enlitic